Renaissance Technologies - AMYLYX PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
Renaissance Technologies ownership history of AMYLYX PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$2,748
-58.3%
150,100
-15.8%
0.01%
-44.4%
Q4 2022$6,588
-99.6%
178,300
+21.8%
0.01%
+350.0%
Q1 2022$1,881,000146,4000.00%
Other shareholders
AMYLYX PHARMACEUTICALS INC shareholders Q4 2023
NameSharesValueWeighting ↓
Perceptive Advisors 5,472,033$154,038,0004.47%
Ghost Tree Capital, LLC 550,000$15,483,0004.35%
Ghost Tree Capital, LLC 500,000$14,075,0003.95%
Bain Capital Life Sciences Investors, LLC 1,023,214$28,803,0003.44%
Boxer Capital, LLC 2,084,000$58,665,0003.30%
Alpha Wave Global, LP 700,635$19,723,0002.33%
Soleus Capital Management, L.P. 429,336$12,086,0001.64%
Ikarian Capital, LLC 250,000$7,037,0001.40%
Cormorant Asset Management, LP 610,000$17,172,0001.20%
SECTORAL ASSET MANAGEMENT INC 205,400$5,782,0001.14%
View complete list of AMYLYX PHARMACEUTICALS INC shareholders